prostate cancer

Shanghai and Hong Kong, China, November 8, 2026 Antengene Corporation Limited has announced the presentation of promising preclinical research...

New Brunswick, New Jersey, USA, November 8, 2026 Johnson & Johnson has announced encouraging Phase 1 clinical trial results...

PHILADELPHIA — September 29, 2026 Medicus Pharma Ltd. announced that it has submitted an optimized seamless Phase 2b/3 registration-intent...

NEW YORK — September 28, 2026 Pfizer Inc. announced that it will present data from 45 company-sponsored, investigator-sponsored and...

Irvine, California, U.S., September 18, 2026 Avenda Health, an artificial intelligence-powered medical technology company focused on prostate cancer care,...

MELBOURNE, Australia and INDIANAPOLIS, September 2, 2026 Telix Pharmaceuticals Limited has completed enrollment of 350 patients in its Phase...

REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...

Melbourne, Australia and Indianapolis, Indiana, U.S. | August 20, 2026 Telix Pharmaceuticals reported strong first-half 2026 performance, highlighting continued...

Boston, Massachusetts, August 17, 2026 PhaseV, an artificial intelligence and machine learning company focused on clinical development, has announced...

Ramat Gan, Israel, August 17, 2026 Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology...